|3.46||+0.04 / +1.17%|
Data as of 3:59pm ET
|3.46||0.00 / 0.00%|
The 8 analysts offering 12-month price forecasts for Avanir Pharmaceuticals Inc have a median target of 7.50, with a high estimate of 13.00 and a low estimate of 4.00. The median estimate represents a +116.76% increase from the last price of 3.46.
The current consensus among 8 polled investment analysts is to Buy stock in Avanir Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.